YB-800BS2

N/A

Report date: 2024/12/17 17:29:33

Base Information

Drug NameYB-800BS2

Drug Alias NameYB-800BS2

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionNeuronal pentraxin receptor inhibitors

TargetsNeuronal pentraxin receptor

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesYmmunobio AG

China Registration ClassN/A

Develop Information

Active CompaniesYmmunobio AG

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A